Safety, Tolerability, and Immunogenicity of V114 in Healthy Infants (V114-029)

NCT03893448 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1720

Enrollment

INDUSTRY

Sponsor class

Conditions

Pneumococcal Infections
Pneumococcal Vaccines

Interventions

BIOLOGICAL: V114
BIOLOGICAL: Prevnar 13™
BIOLOGICAL: RotaTeq™
BIOLOGICAL: Pentacel™
BIOLOGICAL: RECOMBIVAX HB™
BIOLOGICAL: VAQTA™
BIOLOGICAL: MMR II™
BIOLOGICAL: VARIVAX™
BIOLOGICAL: HIBERIX™

Sponsor

Merck Sharp & Dohme LLC